- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- November 2023
- 171 Pages
Global
From €5318EUR$5,500USD£4,537GBP
- Report
- March 2024
- 186 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- March 2024
- 184 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- March 2024
- 199 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- March 2024
- 180 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- March 2024
- 196 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- June 2023
- 150 Pages
Global
From €5753EUR$5,950USD£4,909GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,125GBP
- Report
- March 2024
- 197 Pages
Global
From €3262EUR$3,374USD£2,784GBP
€3625EUR$3,749USD£3,093GBP
- Report
- April 2024
- 578 Pages
Global
From €5270EUR$5,450USD£4,496GBP
- Report
- June 2023
- 100 Pages
Global
From €5753EUR$5,950USD£4,909GBP
- Report
- March 2024
- 141 Pages
Global
From €3770EUR$3,899USD£3,217GBP
- Report
- January 2024
- 149 Pages
Global
From €3770EUR$3,899USD£3,217GBP
- Report
- April 2024
- 118 Pages
Global
From €5270EUR$5,450USD£4,496GBP
- Report
- February 2024
- 250 Pages
Global
From €4834EUR$5,000USD£4,125GBP
Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation.
The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy.
Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more